Tech Company Financing Transactions

Tobira Therapeutics Funding Round

Tobira Therapeutics closed a $31 million Series B funding round on 9/30/2010. Investors included Novo Ventures, Canaan Partners and Domain Associates.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

701 Gateway Blvd. 200
South San Francisco, CA 94080
USA

Phone

(650) 741-6625

Website

www.tobiratherapeutics.com

Email Address

[email protected]

Overview

Tobira Therapeutics acquires, develops, and commercializes innovative products for the treatment of important unmet medical needs in infectious diseases such as HIV/AIDS, hepatitis, and other associated infectious conditions.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Laurent Fischer

        

Chief Financial Officer

Christopher Peetz

        

Chief Medical Officer

Eric Lefebvre

        

Chief Operating Officer

Helen Jenkins

        

VP - Regulatory Affairs

Martine Kraus

        

Browse more venture capital transactions:

Prev: 9/30/2010: SynDevRx venture capital transaction
Next: 9/30/2010: CriticalMix venture capital transaction

Share this article

About Our VC Transactions Data

We record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary